Gianfranco Catalano

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review.

Journal: Expert review of anticancer therapy
Published: January 08, 2026

Retraction Note: Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in K562 cells.

Retraction Note: Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in K562 cells.

Journal: BMC cancer
Published: November 26, 2025

Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia.

Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia.

Journal: Expert opinion on pharmacotherapy
Published: October 27, 2025

Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Journal: Journal of personalized medicine
Published: June 26, 2025

Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632-6658.

Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632-6658.

Journal: Current oncology (Toronto, Ont.)
Published: May 27, 2025

Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2-Related Factor 2 Function in Leukemia and Other Cancers.

Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2-Related Factor 2 Function in Leukemia and Other Cancers.

Journal: Cells
Published: April 14, 2025

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

Journal: Leukemia
Published: March 21, 2025

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.

Journal: Current oncology (Toronto, Ont.)
Published: September 13, 2024

MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.

MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.

Journal: Leukemia
Published: December 28, 2022

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Journal: Cancers
Published: April 26, 2022

NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Journal: Mediterranean journal of hematology and infectious diseases
Published: August 26, 2020

PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells.

PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells.

Journal: Cancers
Published: December 20, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026